| GBP millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 61.6 | 61.2 | 58.6 | 53.2 | 54.1 | 53.8 | −0.4% | |
| Cost of revenue | 37.1 | 35.4 | 35.5 | 31.7 | 30.1 | 30.0 | −0.2% | |
| Gross profit | 24.5 | 25.7 | 23.0 | 21.5 | 24.0 | 23.8 | −0.6% | |
| Research & development | 0.5 | 0.5 | 0.3 | 0.4 | 0.4 | 0.6 | +48.0% | |
| Operating expenses | 19.1 | 20.4 | 21.6 | 20.0 | 20.7 | 21.4 | +3.6% | |
| Operating income | 5.4 | 5.3 | 1.5 | 1.5 | 3.3 | 2.4 | −26.8% | |
| Interest expense | 0.2 | 0.3 | 0.4 | 0.3 | 0.2 | 0.1 | −27.3% | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Pre-tax income | 5.2 | 3.5 | 0.7 | (3.3) | 3.4 | 2.6 | −22.6% | |
| Income tax | 0.8 | 0.3 | 0.2 | 0.3 | 0.9 | 0.5 | −43.9% | |
| Net income | 4.3 | 3.1 | 0.5 | (3.5) | 2.5 | 2.1 | −14.7% | |
| EPS, basic (per share) | 0.07 | 0.05 | 0.01 | (0.05) | 0.04 | 0.03 | −14.8% | |
| EPS, diluted (per share) | 0.06 | 0.04 | 0.01 | (0.05) | 0.03 | 0.03 | −7.3% | |
| EBITDA | 6.9 | 6.9 | 3.1 | 3.2 | 4.9 | 4.0 | −18.8% | |
| Depreciation & amortization | 1.5 | 1.6 | 1.6 | 1.7 | 1.6 | 1.6 | −2.0% | |
| Weighted average shares (shares) | 64,757,807 | 67,372,553 | 69,166,461 | 68,433,858 | 68,435,383 | 68,493,160 | +0.1% | |
| Weighted average diluted shares (shares) | 73,546,563 | 78,054,389 | 78,700,936 | 68,433,858 | 74,641,070 | 68,823,928 | −7.8% | |
| Gross margin | 39.7% | 42.1% | 39.3% | 40.3% | 44.4% | 44.3% | −0.1 pts | |
| Operating margin | 8.7% | 8.7% | 2.5% | 2.8% | 6.1% | 4.5% | −1.6 pts | |
| Net margin | 7.0% | 5.1% | 0.9% | −6.6% | 4.5% | 3.9% | −0.7 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
